Dr. James S. Sim, MD
Nephrology (Kidney) (Nephrology Physician)
5131 Odonovan Dr Ste 100
Baton Rouge, LA 70808
Who else practices at this address →
East Baton Rouge Parish includes primary care (46% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Medical College of Georgia School of Medicine (2005)
- Years since graduation
- 21
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 382
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Medical school: Medical College of Georgia School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
LA license MD.206715
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Our Lady of the Lake Regional Medical Center Baton Rouge, LA
- Ochsner Medical Center - Baton Rouge Baton Rouge, LA
- Baton Rouge General Medical Center Baton Rouge, LA
Medical groups
- Ochsner Clinic LLC (2,864 clinicians)
- Renal Associates of Baton Rouge, LLC (26 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 382
- Services billed
- 1,362
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 3,335 | 34 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 266 | 135 |
| Established patient office or other outpatient visit, 30-39 minutes | 263 | 192 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 212 | 58 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 96 | 45 |
| Hemodialysis procedure with physician evaluation | 90 | 71 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 71 | 41 |
| Injection of drug or substance under skin or into muscle | 53 | 34 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 49 | 47 |
| New patient office or other outpatient visit, 45-59 minutes | 28 | 28 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Losartan Potassium Other prescribers in Baton Rouge, LA | 157 |
| Jardiance (empagliflozin) Other prescribers in Baton Rouge, LA | 136 |
| Velphoro (sucroferric oxyhydroxide) | 110 |
| Sevelamer Carbonate Other prescribers in Baton Rouge, LA | 85 |
| Amlodipine Besylate Other prescribers in Baton Rouge, LA | 79 |
| Furosemide Other prescribers in Baton Rouge, LA | 61 |
| Auryxia (ferric citrate) | 52 |
| Doxazosin Mesylate Other prescribers in Baton Rouge, LA | 45 |
| Procrit (epoetin alfa) | 35 |
| Carvedilol Other prescribers in Baton Rouge, LA | 30 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 35 payments worth $786 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $163 |
|---|---|
| Amgen Inc. | $154 |
| Fresenius USA Marketing, Inc. | $85.47 |
| Mallinckrodt Hospital Products Inc. | $70.71 |
| Bayer HealthCare Pharmaceuticals Inc. | $62.47 |
| Novo Nordisk Inc | $44.01 |
| Calliditas Therapeutics US Inc. | $40.63 |
| Lilly USA, LLC | $40.45 |
| Food and Beverage | $786 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.